Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation. [electronic resource]
Producer: 20180917Description: 5513-5520 p. digitalISSN:- 1791-7530
- Aged
- Antiviral Agents -- administration & dosage
- Carbamates
- Drug Interactions
- Drug Monitoring
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C -- blood
- Humans
- Imidazoles -- administration & dosage
- Immunosuppressive Agents -- adverse effects
- Isoquinolines -- administration & dosage
- Liver Transplantation -- adverse effects
- Living Donors
- Male
- Middle Aged
- Prospective Studies
- Pyrrolidines
- Recurrence
- Sulfonamides -- administration & dosage
- Tacrolimus -- adverse effects
- Time Factors
- Treatment Outcome
- Valine -- analogs & derivatives
- Viral Load
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.